CD8+T cells specifically express granzyme K and activate complement system associated with inflammation recurrence
With the support of the National Natural Science Foundation of China
project (approval number: T2225005), Professor Qi Hai, Associate Professor Wang
Jianbin, Associate Researcher Liu Xin from Tsinghua University, and Professor
Zhang Luo from Beijing Tongren Hospital have made new progress in the
immunological mechanism of airway inflammation recurrence. The research results,
titled "GZMK expressing CD8+T cells promote recurrent airway inflammatory
diseases", were published in the journal Nature on January 15, 2025. The link to
the paper is: https://doi.org/10.1038/s41586-024-08395-9 .
Chronic sinusitis with nasal polyps is a type of upper respiratory disease
driven by allergic inflammation, with over 100 million patients in China
currently. Although nasal polyps can be removed through surgery, they recur
frequently and the cause is unknown. In response to the above challenges,
researchers used single-cell transcriptome and lymphocyte receptor library
sequencing to identify a type of memory CD8+T cells in nasal polyp tissue of
patients; A new pathway for T cells to specifically express granzyme K and
activate complement was identified through protein mass spectrometry; And in a
mouse model of allergic asthma, the clearance of CD8+T cells by granzyme K
significantly reduced lung inflammation in mice. This study reveals a novel
immunological mechanism for the prolonged recurrence of allergic and airway
inflammatory diseases, providing new strategies for the treatment of recurrent
airway inflammation.